Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan

Flindr Receives €20 Million to Advance Precision Cancer Treatments with RNF31 Inhibitor

AstraZeneca's $2.4 Billion Strategic Move: Acquiring Fusion for Radiopharmaceutical

Gilead and Merus Forge $1.5 Billion Oncology Alliance to Novel Cancer Treatments

The Global CAR T-Cell Therapy Market's Ascent: From $8.2 B in 2022 to $11.2 B by 2030

J&J's $2 Billion Strategic Acquisition of Ambrx Biopharma: Leading in ADC Oncology

Scemblix Outperforms Standard TKIs in Phase III Chronic Myeloid Leukemia Trial

Merck's $680 Million Strategic Move to Boost Oncology Pipeline with Harpoon Acquisition

Novartis Launches Its Largest RLT Facility in Indianapolis, Enhancing Pluvicto Production

AbbVie and Umoja Collaborate to Advance CAR-T Cell Therapy

Boehringer Ingelheim Partners with Ribo for Liver Disease Therapies in $2 Billion Deal

Boehringer Ingelheim and 3T Forge Alliance to Advance Cancer Immunotherapies

Novo Nordisk, Omega and Cellarity Collaborate to Reshape Future of Obesity and MASH

Roche and MediLink Collaborate to Develop Next-Generation Cancer Drug YL211

Bloodstream Infection Treatment: Phase 3 Trial of Mino-Lok Completed

Novartis and Voyager Enter Strategic Collaboration to Advance Novel Gene Therapies

Astellas and Elpiscience Collaborate on Bispecific Macrophage Engager for Cancer Research

Bristol Myers Squibb Expands Oncology Line with $4.1 Billion RayzeBio Acquisition

Strategic Leap in Neuropharma: Bristol Myers' $14 Billion Acquisition of Karuna

Gilead and Compugen Collaborate on Cancer Immunotherapy in New Licensing Deal

Depixus and Daiichi Sankyo Collaborate to Accelerate RNA-targeted Drug Discovery

Lilly's Zepbound Demonstrates Efficacy in Weight Loss with a 26% Reduction

AstraZeneca and AbelZeta Jointly Co-Develop CAR-T Cancer Therapy in China

AbbVie's Giant Move in Neuroscience: $8.7 Billion Acquisition of Cerevel

After FDA Approval, Zepbound Available in US Pharmacies for Battling Obesity

China's NMPA Accepts Everest's Zetomipzomib for Treatment of Lupus Nephritis

Biohaven Presents Promising Data for new epilepsy drug BHV-7000 at AES 2023

Roche's Strong Entry into Obesity Market Through $2.7 B Acquisition of Carmot

PsychoGenics and Roche Agreement Advances Neuropsychiatric Treatments